A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : RASSF1A / Ras association domain family 1A

[Related PubMed/MEDLINE]
Total Number of Papers: 223
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   RASSF1A  (>> Co-occurring Abbreviation)
Long Form:   Ras association domain family 1A
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Association of promoter methylation of RASSF1A and KRAS mutations in non-small cell lung carcinoma in Kashmiri population (India). ADC, ASO-PCR, KRAS, NSCLC, SCC, TSG
2020 DNA Methylation in Human Breast Cancer Cell Lines Adapted to High Nitric Oxide. BRCA1, DCC, MGMT, NO, SFRP1
2020 RASSF1A: A promising target for the diagnosis and treatment of cancer. ---
2020 Tricistronic expression of MOAP-1, Bax and RASSF1A in cancer cells enhances chemo-sensitization that requires BH3L domain of MOAP-1. IRES, MBR, MBRX, MOAP-1
2019 A RASSF1A-HIF1alpha loop drives Warburg effect in cancer and pulmonary hypertension. HIF-1alpha, PH
2019 Diagnostic value of RASSF1A methylation for breast cancer: a meta-analysis. AUC, BC, DOR, MSP
2019 EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation. EBNA3C
2019 Multidrug resistance affects the prognosis of primary epithelial ovarian cancer. GSTP1, LRP, MSP, PEOC, RT-qPCR
2019 Prognostic value of RASSF1A methylation status in non-small cell lung cancer (NSCLC) patients: A meta-analysis of prospective studies. NSCLC, OS
10  2019 Ras association domain family 1 isoform A suppresses colonic tumor cell growth through p21WAF1 activation in a p53-dependent manner. MDM2
11  2019 Ras association domain family protein 1a hypermethylation and PD-L1 expression in ovarian cancer: A retrospective study of 112 cases. OC
12  2019 Ras-association domain family 1 (RASSF1A) gene regulates progression, migration and invasion of bladder cancer. DFS, MTT
13  2019 RASSF1-AS1, an antisense lncRNA of RASSF1A, inhibits the translation of RASSF1A to exacerbate cardiac fibrosis in mice. AS, lncRNAs, mRNA
14  2019 RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis, and metastasis-an updated review. ---
15  2019 The tumor suppressor RASSF1A modulates inflammation and injury in the reperfused murine myocardium. I/R
16  2019 When Hippo meets actin in the nucleus. MST2
17  2018 Associations of RASSF1A, RARbeta, and CDH1 promoter hypermethylation with oral cancer risk: A PRISMA-compliant meta-analysis. CNKI, ORs, RARbeta
18  2018 Diagnostic value of RASSF1A hypermethylation in colorectal cancer: a meta-analysis. AUC, CIs, CRC, ORs, SROC
19  2018 MicroRNA‑181a promotes cell proliferation and inhibits apoptosis in gastric cancer by targeting RASSF1A. CDC25A, miR
20  2018 Polymorphisms of the Ras-Association Domain Family 1 Isoform A (RASSF1A) Gene are Associated with Ovarian Cancer, and with the Prognostic Factors of Grade and Stage, in Women in Southern China. PCR, SNPs
21  2018 Relationship between RAS Association Domain Family Protein 1A Promoter Methylation and the Clinicopathological Characteristics in Patients with Ovarian Cancer: A Systematic Meta-Analysis. LMP
22  2018 Suppressive efficiency of RASSF1A in endometrial carcinoma via inhabiting estrogen receptor alpha expression and ERK pathway activation. ERK
23  2018 The FENDRR/miR-214-3P/TET2 axis affects cell malignant activity via RASSF1A methylation in gastric cancer. FENDRR, FISH, GC, miR-214-3p, MSP
24  2018 Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients. BPH, GSTP1, PCa, PPM, PSA, USCs
25  2017 Association Between RASSF1A Promoter Methylation and Testicular Germ Cell Tumor: A Meta-analysis and a Cohort Study. MGMT, OR, TGCT
26  2017 Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma. AUC, NPC
27  2017 Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders. B-LPD, CIMP, DLBCL, EBV, MTX, non-MTX-BLPD, RA
28  2017 Establishment of two data mining models of lung cancer screening based on three gene promoter methylations combined with telomere damage. DT, FHIT, ROC, RTL, SVM
29  2017 HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. BGS, FNR, HPV, MSP
30  2017 Impact of Natural Compounds on DNA Methylation Levels of the Tumor Suppressor Gene RASSF1A in Cancer. TSG
31  2017 Impact of RASSF1A gene methylation on the metastatic axillary nodal status in breast cancer patients. MSP
32  2017 Potential of RASSF1A promoter methylation as biomarker for endometrial cancer: A systematic review and meta-analysis. EC, OR
33  2017 Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy. CRC, MSP, OR
34  2017 Promoter methylation of tumor-related genes as a potential biomarker using blood samples for gastric cancer detection. APC, DAPK, GC, GSTP1, MGMT, MLH1
35  2017 Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA). HR, OS
36  2017 RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis. CIs, ORs
37  2017 Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosis. AC, APC, AUC, RARbeta2, SCC, SHOX2
38  2017 The loss-of-function of DNA methyltransferase 1 by siRNA impairs the growth of non-small cell lung cancer with alleviated side effects via reactivation of RASSF1A and APC in vitro and vivo. APC, DNMT, TSGs
39  2017 The relationship between RASSF1A promoter methylation and thyroid carcinoma: A meta-analysis of 14 articles and a bioinformatics of 2 databases (PRISMA). DFS, GEO
40  2017 Value of the level of methylation of RASSF1A and WIF-1 in tissue and serum in neoadjuvant chemotherapeutic assessment for advanced breast cancer. CR, PD, PR, SD, WIF
41  2017 [Association of etheno-DNA adduct and DNA methylation level among workers exposed to diesel engine exhaust]. 5mC, DEE, MGMT
42  2016 Aberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-Analysis. CIs, CNKI, HNSCC, ORs
43  2016 Association between RASSF1A promoter methylation and renal cell cancer susceptibility: a meta-analysis. ORs
44  2016 beta-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients. CRC, NHERF1
45  2016 Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer. CDH13, EC, RT-PCR, WIF-1
46  2016 Delineating the effect of demethylating agent 5-aza-2'-deoxycytidine on human Caco-2 colonic carcinoma cells. ---
47  2016 Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells. BGS, DNMTs, HDACs, MSP, PEITC, PI, TSA
48  2016 Fetal RHD Genotyping Using Real-Time Polymerase Chain Reaction Analysis of Cell-Free Fetal DNA in Pregnancy of RhD Negative Women in South of Iran. cffD- NA, GA, qPCR, wks
49  2016 Methylation status and protein expression of RASSF1A in endometriosis. EMS, EMS, MSP
50  2016 Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancer. APC, CRC, mCRC, MSP, oCRC
51  2016 Quantitative detection of TUSC3 promoter methylation -a potential biomarker for prognosis in lung cancer. MethyQESD, MTSS1, PDCD4, RASAL1, TUSC3
52  2016 Ras-Association Domain Family 1 Isoform A (RASSF1A) Gene Polymorphism rs1989839 is Associated with Risk and Metastatic Potential of Osteosarcoma in Young Chinese Individuals: A Multi-Center, Case-Control Study. OS
53  2016 Renal Cancer Diagnosed by Noninvasive Methods from Body Fluids by Quantitative Methylation-Specific PCR(qMSP). AUC, qMSP, RCC, ROC
54  2016 The tumor suppressive role of RASSF1A in osteosarcoma through the Wnt signaling pathway. GSK3beta, MMP-7, mRNA, MST1
55  2016 [Methylation status of PCDH10 and RASSF1A gene promoters in colorectal cancer]. CRC, MSP, PCDH10
56  2015 Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients. BC, BRCA1, CI, ORs, RARB
57  2015 Chemopreventive mechanism of polypeptides from Chlamy Farreri (PCF) against UVB-induced malignant transformation of HaCaT cells. DNMTs, MMP9, PCF, UVB
58  2015 Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection. AUC, CHB, HCC, LC, OS
59  2015 CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis. ---
60  2015 CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers. ADAM23, APC, BC, CXCL12, ER, LNMs, PL, PTs
61  2015 DNA methylation markers and serum alpha-fetoprotein level are prognostic factors in hepatocellular carcinoma. AFP, HCC, nested-MSP
62  2015 Lentivirus-mediated RASSF1A expression suppresses aggressive phenotypes of gastric cancer cells in vitro and in vivo. CEA
63  2015 Modulator of apoptosis 1 (MOAP-1) is a tumor suppressor protein linked to the RASSF1A protein. MOAP-1
64  2015 Promoter methylation of p16 and RASSF1A genes may contribute to the risk of papillary thyroid cancer: A meta-analysis. CBM, ORs, PTC, RDs
65  2015 Regulation of demethylation and re-expression of RASSF1A gene in hepatocellular carcinoma cell lines treated with NCTD in vitro. MSP, MTT, NCTD, RT-PCR
66  2015 The Association of Ala133Ser Polymorphism and Methylation in Ras Association Domain Family 1A Gene With Unfavorable Prognosis of Hepatocellular Carcinoma. HCC
67  2015 Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma. AUC, cfDNA, CTCs
68  2015 [Meta-analysis of the Association between RASSF1A Gene Promoter Methylation and Non-small Cell Lung Cancer]. CI, NSCLC, OR
69  2014 Administration of recombinant human granulocyte-colony-stimulating factor does not induce long-lasting detectable epigenetic alterations in healthy donors. DNMT, RARB, rHuG-CSF
70  2014 Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis. QMSP
71  2014 Association between RASSF1A Ala133Ser polymorphism and cancer susceptibility: a meta-analysis involving 8,892 subjects. CIs, ORs
72  2014 Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis. CI, OR
73  2014 Cell cycle restriction is more important than apoptosis induction for RASSF1A protein tumor suppression. ---
74  2014 DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1/2. AF, DNMT3A
75  2014 Intact expression status of RASSF1A in acute myeloid leukemia. AML
76  2014 Methylation status and protein expression of RASSF1A in breast cancer patients. ---
77  2014 Microtubule segment stabilization by RASSF1A is required for proper microtubule dynamics and Golgi integrity. ---
78  2014 Mitotic arrest by tumor suppressor RASSF1A is regulated via CHK1 phosphorylation. Chk1
79  2014 RASSF1A promoter hypermethylation is a strong biomarker of poor survival in patients with salivary adenoid cystic carcinoma in a Chinese population. ACC, BSP, LOH, MSP
80  2014 RASSF1A promotes apoptosis and suppresses the proliferation of ovarian cancer cells. CDC20, HRAS, PPI, qRT-PCR, STK
81  2014 RASSF1A suppresses proliferation of cervical cancer cells. ---
82  2014 The association between RASSF1A promoter methylation and prostate cancer: evidence from 19 published studies. GS, OR, PCa
83  2014 The tumour suppressor Ras-association domain family protein 1A (RASSF1A) regulates TNF-alpha signalling in cardiomyocytes. TNF-alpha, TNFRC, TNFRs, WT
84  2013 Association between Ras association domain family 1A promoter methylation and hepatocellular carcinoma: a meta-analysis. DOR, HCC, NLR, PLR
85  2013 Association between RASSF1A promoter methylation and ovarian cancer: a meta-analysis. ORs, TSG
86  2013 Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis. OR, PCa, PSA
87  2013 Elevated plasma levels of hypermethylated RASSF1A gene sequences in pregnant women with intrahepatic cholestasis. ICP
88  2013 Epidermal growth factor receptor (EGFR)-RAS signaling pathway in penile squamous cell carcinoma. EGFR, SCC
89  2013 Loss of RASSF1A expression in colorectal cancer and its association with K-ras status. CRC
90  2013 Methylation of RASSF1A gene promoter is regulated by p53 and DAXX. ALL, DNMT1, MDM2
91  2013 Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associated with risk of esophageal and gastric cardia cancers in Chinese population from high incidence area in northern China. ESCC, GCA, MSP, PCR
92  2013 RASSF1A methylation indicates a poor prognosis in hepatoblastoma patients. ---
93  2013 RASSF1A Promoter Methylation Levels Positively Correlate with Estrogen Receptor Expression in Breast Cancer Patients. ER, ESR1, PR, Syk, TIMP3
94  2013 RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma. AREG, HCC, MST, YAP
95  2013 RASSF1A: a potential novel therapeutic target against cardiac hypertrophy. ---
96  2013 Study of genetic and epigenetic alterations in urine samples as diagnostic markers for prostate cancer. AUC, DRE, ERG, MSP-PCR, PCA3, PSA, RT-PCR, SPINK1, TMPRSS2-ERG
97  2013 The tumor suppressor gene, RASSF1A, is essential for protection against inflammation -induced injury. DSS, NF-kappaB, TLR, YAP
98  2013 [Quantitative detection of APC/RASSF1A promoter methylation in the plasma of patients with cervical diseases]. APC, FIGO, qMSP
99  2012 Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma. BAP, DAPK, LC, MPM, RARbeta
100  2012 An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial. DAPK1, DFS, NSCLC, OS